Skip to main content
v2026.11,986 entries · CC-BY 4.0

Editorial · CASRAI · Funding lifecycle and financial vocabulary

EUP OHAMR Opens 31 Million Euro Horizon Europe Joint Call on Antimicrobial Resistance Transmission

The European Partnership on One Health AMR has launched a €31M joint call funding transnational consortia to model and curb resistance transmission.

Published 22 Nov 2026· 7 minute read
Microbiological seeding on an agar Petri dish in a sterile laminar flow hood
Photo: Nycterixnycterix / Wikimedia Commons, CC BY 4.0 (cropped). Source · Licence

On November 18, 2026, the European Partnership on One Health Antimicrobial Resistance (EUP OHAMR) launched its Joint Transnational Call 2027, committing approximately €31 million across 37 funding organisations in 27 countries to support collaborative research investigating antimicrobial resistance transmission dynamics across human, animal, and environmental ecosystems.

Consortium Funding and Transnational Scope

The call, titled “Understand, Model and Stop AMR Transmission,” marks the second annual joint call organized under EUP OHAMR. Co-funded by the European Commission under the Horizon Europe programme, the call pools national and regional budgets with EU matching funds. Financial support expanded substantially between planning and launch: preliminary notices in October 2026 estimated a €28 million envelope from 33 agencies, but final commitments reached €31 million from 37 organisations across 27 nations upon the formal November 18 opening.

Launched in June 2025 as a 10-year co-funded partnership, EUP OHAMR succeeds the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). While the 2026 call targeted clinical treatments and protocol adherence, the 2027 call tackles ecological transmission pathways and predictive modelling. The initiative coordinates research across four programmes: research funding, capacity strengthening, data exploitation, and policy impact. Consortia can leverage broader European mechanisms for research infrastructure funding to access harmonized surveillance platforms, repositories, and computational resources across participating borders.

Three Research Priorities: Modelling, Commensals, and Hotspots

Proposals must address Focus Area 1 (“Prevent the emergence and spread of AMR”) of the EUP OHAMR Strategic Research and Innovation Agenda, selecting exactly one of three core topics:

  • Topic 1: Model AMR transmission dynamics to predict emergence and spread for public authorities. Projects must develop transmission models across One Health settings to forecast antibiotic and antifungal resistance emergence. Models must incorporate anthropogenic drivers (such as agricultural practices, trade, migration, armed conflict, and travel) alongside climate shocks (such as heatwaves and floods). These tools aim to identify intervention points for public authorities, drawing on epidemiological scenario modelling to guide regulatory policy.
  • Topic 2: Understand host commensal micro-organisms in AMR dynamics and develop selective decolonisation tools. Commensal bacteria and fungi in humans and animals act as hidden reservoirs for resistance genes. Projects must examine transmission between commensals and pathogens, developing targeted solutions to decolonise resistant reservoir strains without disrupting protective microbiota.
  • Topic 3: Reduce resistant bacteria, fungi, and resistance genes in environmental hotspots. Hotspots include wastewater treatment plants, hospital effluent pipelines, pharmaceutical manufacturing discharges, and agricultural manure storage. Proposals must test innovative decontamination solutions and measure their epidemiological impact across at least two One Health domains, mandating both human and environmental settings.

Proposals must establish practical feasibility, clear pathways to societal uptake, and transnational value. Participation by industry, start-ups, and small and medium-sized enterprises (SMEs) is encouraged across all topics.

Consortium Architecture and Eligibility Rules

To qualify, international consortia must comprise at least three eligible partners requesting funding from three different participating countries, including at least two based in EU Member States or Horizon Europe Associated Countries. Standard consortia may include up to six partners, encompassing funded institutions and self-funded external collaborators.

Consortia can expand their ceiling to seven partners by meeting at least one strategic criterion: including a partner from an under-represented country (Czech Republic, Hungary, Latvia, Lithuania, Malta, Moldova, Poland, or Slovakia); a Principal Investigator who is an early-career researcher; or an active industry partner or SME. Furthermore, no single funding organisation may fund more than two partners in the same consortium.

Each consortium must designate a project coordinator in a grant consortium to act as the single point of contact with the Joint Call Secretariat. Participating institutional partners in a grant consortium must submit signed letters of intent at both pre-proposal and full proposal stages. Grantees must also establish a formal consortium agreement governing intellectual property, data sharing, and decision-making prior to project launch.

Under EU restrictive measures, legal entities established in Russia, Belarus, or non-government-controlled territories of Ukraine, as well as entities majority-owned by Russian legal persons, are strictly barred from participating in any capacity.

Key Deadlines and Evaluation Milestones

The call operates a two-stage competitive submission process via the centralised PT Outline portal. The table below details key milestone dates:

Milestone Stage Calendar Date Operational Requirement
Call Launch November 18, 2026 Official call publication and PT Outline submission platform opens
Applicant Information Webinar November 25, 2026 (13:30 CET) Online briefing for prospective coordinators and partner networking
Pre-Proposal Deadline February 1, 2027 (13:00 CET) Submission of outline proposals, PIC codes, and signed letters of intent
Stage 1 Assessment Results May 5, 2027 Joint Call Secretariat communicates pre-proposal outcomes by email
Full Proposal Deadline June 23, 2027 (13:00 CET) Invited consortia submit full technical proposals and workpackages
Final Funding Decision November 4, 2027 Secretariat sends final funding recommendations to project coordinators
Public Results Announcement November 2027 Award announcements published during World AMR Awareness Week
Project Start Window December 2027 – April 2028 Consortium agreements signed; 3-year research projects commence

Principal Investigators face strict limits: an individual researcher may apply for at most two proposals across the call, serving as coordinator on at most one.

National Funder Rules and Dual Submission Platforms

Because EUP OHAMR is a co-funded partnership rather than a single European Commission grant, financial allocations are governed by national eligibility rules and domestic cost reimbursement rates rather than uniform Horizon Europe terms. Programme intelligence tracked by Grantsby emphasizes that participating agencies enforce independent budget caps, overhead allowances, and eligible cost structures.

Several participating countries impose specific operational constraints:

  • The Netherlands: The Netherlands Organisation for Health Research and Development (ZonMw) limits Dutch funding eligibility exclusively to Topic 1 (transmission modelling) and Topic 3 (environmental hotspots). Dutch applicants must also satisfy national state-aid status rules for research organisations.
  • Sweden: The Swedish Research Council (Vetenskapsrådet) provides a minimum grant of 1.2 million SEK (approximately €110,000) per Swedish partner and a maximum of 3.5 million SEK (approximately €321,000) per project for up to two Swedish partners, plus an additional 500,000 SEK (approximately €45,000) coordination allowance. Swedish applicants must complete a mandatory parallel application within Sweden’s Prisma system by February 8, 2027, one week after the central pre-proposal closure.
  • United Kingdom: UK researchers participate via the Medical Research Council (MRC), the Department of Health and Social Care (DHSC), and Innovate UK, each applying specific remit boundaries and cost structures.
  • France and Germany: The Agence Nationale de la Recherche (ANR) and German federal agencies manage domestic eligibility, with the overall Joint Call Secretariat administered by the German DLR Project Management Agency in Bonn.

Operational Guidance for Research Offices and Principal Investigators

University research administration offices and prospective applicants should prepare several administrative requirements ahead of the February 2027 pre-proposal deadline:

  • Participant Identification Codes (PIC): All participating academic departments, clinical bodies, and industry partners must obtain a validated PIC through the European Commission Funding & Tenders Opportunities portal. Pre-proposals cannot be submitted in PT Outline without valid PICs for all consortium members.
  • Partner Matching Platforms: Consortia should utilize the official EUP OHAMR Partner Search Tool early. Recruiting partners from Central and Eastern European nations or early-career researchers directly secures the expanded seven-partner consortium allowance.
  • Monitoring Dual Portals: Research offices must monitor domestic submission portals alongside PT Outline. As with Sweden’s Prisma deadline on February 8, 2027, several national agencies require parallel domestic filings and institutional authorisations shortly after the central deadline.
  • Pre-Submission Eligibility Inquiries: Because national agencies can declare domestic partners ineligible—risking the disqualification of the entire consortium—applicants must instruct each partner to contact their national contact point to confirm budget rules, eligible overheads, and clinical or environmental scopes prior to submission.
  • Webinar Registration: Prospective coordinators and partners should register for the Secretariat’s applicant briefing webinar on November 25, 2026 at 13:30 CET, which will cover application mechanics and consortium criteria.

Sources

Ask CASRAI · full access

Ask about this story

Full access: large monthly usage, up to 10 source passages behind each answer, and MCP and API access for Claude Code, Codex and other CLIs. Cancel any time.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →